| 摘要 |
The present invention relates to a combination comprising (a) an adenosine A<SUB>2a </SUB>receptor agonist as defined herein and (b) an adrenergic beta2 receptor agonist, for simultaneous, sequential or separate administration by the inhaled route in the treatment of an obstructive airways or other inflammatory disease.
|
